SCHEMBL4054375

SCHEMBL4054375

CCCCOC(=O)NCc1ccccc1-c1[c]nccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.40
RAB9A P51151 4/20 0.40
NPC1 O15118 3/20 0.40
LMNA P02545 2/20 0.40
HSD17B10 Q99714 2/20 0.39
KDM4E B2RXH2 1/20 0.39
KCNA5 P22460 3/20 0.39
FAAH O00519 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
ALDH1A1 P00352 1/20 0.38
NFKB1 P19838 1/20 0.38
STAT1 P42224 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
EPHX1 P07099 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
TSHR P16473 1/20 0.37
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764870 0.81 KCNA5 (0.50) RAB9ANPC1KCNA5CYP1A2L3MBTL1
SCHEMBL3757740 0.80 SETDB1 (0.44) LMNAALDH1A1L3MBTL1HPGDNPSR1
SCHEMBL4239368 0.75 PTPN11 (0.51) SMN1; SMN2RAB9ANPC1LMNAKCNA5
SCHEMBL8802438 0.74 LTB4R2 (0.44) SMN1; SMN2RAB9ANPC1LMNAHSD17B10
SCHEMBL11089043 0.74 HPGD (0.51) SMN1; SMN2RAB9ANPC1LMNAKDM4E
SCHEMBL3758955 0.73 TRPA1 (0.35) SMN1; SMN2LMNAL3MBTL1
SCHEMBL3416627 0.73 RIPK1 (0.52) SMN1; SMN2RAB9ANPC1LMNACYP1A2
SCHEMBL7801637 0.73 ALDH1A1 (0.55) SMN1; SMN2RAB9ANPC1LMNAHSD17B10
SCHEMBL6504884 0.73 FAAH (0.44) SMN1; SMN2RAB9ANPC1LMNAHSD17B10
SCHEMBL3757718 0.72 LTA4H (0.44) KDM4EKCNA5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009122148-A1 FUSED THIOPHENE AND THIAZOLE DERIVATIVES AS PI3K KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-10-08 WO disclosed